Long-term follow-up of patients with high-risk basal cell carcinoma treated with interferon

Authors

  • Carla Minaudo British Hospital, City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v30i2.2585

Keywords:

cell carcinoma, interferón

Abstract

Prospective observational study in a cohort of patients from three health centers in Cuba, with a 5-year follow-up.

195 patients with high-risk basal cell carcinoma (HR-BCC) on the face who were not candidates for surgical treatment were selected.

A predesigned combination of interferon (INF) a2b and g was used, applied by dermatologists at a dose of 10.5 x 106 IU intradermally perilesionally. The frequency of treatment was three weeks and the total duration was 3 consecutive weeks.

Author Biography

Carla Minaudo, British Hospital, City of Buenos Aires, Argentina

Assistant Physician, Dermatology Service

References

I. Sánchez V, Carpio E, Fardales VE, Martínez B, et ál. Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon. An Bras Dermatol. 2024;99:391-397.

Downloads

Published

2024-05-16

Issue

Vol. 30 No. 2 (2024): May-August

Section

Dermatological Pearls

License

Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Society of Dermatology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.

 

Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor